Geographic Atrophy Patient with Declining Vision Exploring Treatment Options

Opinion
Video

Katherine Talcott, MD, presents the case of a 64-year-old woman with geographic atrophy and a family history of age-related macular degeneration.

Supported in part by ZEISS Professional Education. Content independently developed by Eye Care Network.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Subscribe Now!
Recent Videos
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Sherrol Reynolds, OD, FAAO, values the ophthalmic-optometric collaboration on display at the summit, running from February 14-17, 2025 in San Juan, Puerto Rico.
From new treatments on the horizon for macular degeneration to strengthening comanagement ties, optometrists cite a lot to be excited about in the coming year.
EnVision Summit Co-chairs Sherrol Reynolds, OD, FAAO; Katie Rachon, OD, FAAO, Dipl ABO; Jessica Steen, OD, FAAO, Dipl ABO; and Cecelia Koetting, OD, FAAO, Dipl ABO; express excitement for the upcoming conference and why optometrists should attend.
What was the biggest innovation in eye care in 2024?
Dr Carolyn Majcher chats about GA and posterior uveitis at AAOpt 2024
David Chin Yee, MD, at EyeCon 2024
Dr. Adam Wenick at EyeCon 2024
Katherine Talcott, MD, presenting slides
Emily Chew, MD, outlines her lecture that landed her the Proctor Award at ARVO 2024
Related Content
CRU 2025 graphic

CRU 2025: The latest in treatments for DR, nAMD, and GA

Jordana Joy, Associate Editor
April 9th 2025
Article
Advances in treatment for geographic atrophy

Advances in treatment for geographic atrophy

David S. Boyer, MD;Tina Mac Donald, OD, CDCES, FAAO;Leo P. Semes, OD, FAAO
October 11th 2023
Podcast
CDR-Life completes fifth milestone and is recruiting patients for phase 2 geographic atrophy study - Image credit: Adobe Stock / ©Parradee

CDR-Life completes fifth milestone and is recruiting patients for Phase 2 study of BI 771716

Sydney M Crago, Editor, Modern Retina
March 18th 2025
Article
Ocugen completes dosing in phase 2 ArMaDa clinical trial - Image credit: Adobe Stock / ©nobeastsofierce

Ocugen, Inc. completes dosing in Phase 2 portion of ArMaDa clinical trial for OCU410

Sydney M Crago, Editor, Modern Retina
March 12th 2025
Article
Woman in scrubs holding a pill and glass of water Image credit: AdobeStock/NewAfrica

Cognition Therapeutics announces manuscript publication on oral drug candidate zervimesine (CT1812) for treatment of dry AMD

Jordana Joy, Associate Editor
February 28th 2025
Article
optos MonacoPro captures retinal images in a patient with myopia - Image credit: Optos

Optos ushers in new generation of imaging with MonacoPro ultra-widefield and OCT

Emily Kaiser Maharjan, Assistant Managing Editor
February 19th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.